Jouko A. Sandholm
Turku, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Fluorine-18-Labeled Nucleotide Analogs Targeting Ecto-5'-Nucleotidase (CD73) for Positron Emission Tomography Imaging of Solid Tumors.
Journal: Angewandte Chemie (International ed. in English)
Published: October 21, 2025
Increased primary breast tumor expression of CD73 is associated with development of bone metastases and is a potential biomarker for adjuvant bisphosphonate use.
Journal: Scientific reports
Published: November 25, 2024
Detection of Tn-antigen in breast and prostate cancer models by VVL-labeled red dye-doped nanoparticles.
Journal: Nanomedicine (London, England)
Published: October 09, 2024
Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors.
Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors.
Journal: Journal of medicinal chemistry
Published: January 26, 2022
CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity.
Journal: Cellular and molecular life sciences : CMLS
Published: July 25, 2021
Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition.
Journal: Frontiers in oncology
Published: June 30, 2021
CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer.
Journal: Scientific reports
Published: October 06, 2020
Evaluation of [18F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 16, 2020
Growth Mode and Carbon Source Impact the Surfaceome Dynamics of Lactobacillus rhamnosus GG.
Journal: Frontiers in microbiology
Published: March 15, 2019
Lipid Bilayer-Gated Mesoporous Silica Nanocarriers for Tumor-Targeted Delivery of Zoledronic Acid in Vivo.
Journal: Molecular pharmaceutics
Published: July 25, 2017
Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells.
Journal: Oncotarget
Published: March 13, 2017
Last Updated: 09/26/2026